Latest

18:44
【SUN.KING TECH (00580.HK): Three Subsidiaries to Contribute RMB 5 Million for 25% Stake in TPU AI Chip Joint Venture】On 9 September 2026, Sun.King Technology Group Limited (00580.HK) announced that its subsidiaries Jiashan Sun.King, Sun.King Semiconductor and Wuhan Langde would establish a joint venture, Zhejiang Xuanju Microelectronics Co., Ltd. (registered capital RMB 20 million), focused on high-performance TPU AI chips and industry inference products, with the three subsidiaries contributing RMB 5 million in aggregate for a 25% interest; the participation of Chuangke and Jiashan Yuxin, connected with executive director Mr. Xiang Jie, makes the transaction a connected transaction subject to reporting and announcement but exempt from independent shareholders' approval.
Tag： SUN.KING TECH00580.HKjoint venture company
18:36
【ANJOY FOOD (02648.HK): Hong Kong Subsidiary to Form Joint Venture Vehicle with Partner for Indonesia Investment, with Combined Contribution of at Least USD 74.25 Million】On 9 September 2026, Anjoy Foods Group Co., Ltd. (02648.HK) announced that its wholly-owned Hong Kong subsidiary Hong Kong Anjoy Foods proposed to form a path company with Mutual Strategy Limited under 50.5%/49.5% shareholdings to invest in production and trading subsidiaries in Indonesia, with combined cash contributions of at least USD 74.25 million (including USD 37,496,250 from Anjoy) for producing and selling quick-frozen surimi products and other items; the investment does not constitute a connected transaction or major asset restructuring.
Tag： ANJOY FOOD02648.HKjoint venture
18:32
【FOUNTAIN SET (00420.HK): Proposes Acquisition of 81% Interest in a Vietnam Textile Company for USD 27,945,000, Constituting a Major Transaction】On 9 September 2026, Fountain Set (Holdings) Limited (00420.HK) announced that an indirect wholly-owned subsidiary proposed to acquire an 81% interest in a Vietnam textile company for a cash consideration of USD 27,945,000 (approximately HKD 219,089,000); the target's 100% equity was valued at approximately RMB 240,653,200 on an asset-based basis as of 30 April 2026, with consideration payable in three instalments; the acquisition constitutes a major transaction subject to shareholders' approval, with a circular expected by 31 October 2026.
Tag： FOUNTAIN SET00420.HKacquisition
18:30
【HENGRUI PHARMA (01276.HK): NMPA Accepts Marketing Application for Ruippotipeptide Injection for Adults with Type 2 Diabetes】On 9 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (01276.HK) announced that the NMPA had accepted the marketing authorisation application for Ruippotipeptide Injection, a GLP-1/GIP dual agonist developed by its subsidiary Fujian Shengdi, for glycaemic control in adults with type 2 diabetes; in the pivotal PRIME-2 study the 4 mg group achieved a mean HbA1c reduction of 2.78% with superiority over semaglutide 1 mg (p<0.0001), and cumulative R&D investment is approximately RMB 745.9 million.
Tag： HENGRUI PHARMA01276.HKR&D Progress
18:23
【SWHY (06806.HK): Subsidiary Shenwan Hongyuan Securities Issues RMB 2 Billion Perpetual Subordinated Bonds (Tranche 2) at Coupon Rate of 1.89%】On 9 September 2026, Shenwan Hongyuan Group Co., Ltd. (06806.HK) announced the completion of the issuance of the 2026 Tranche 2 perpetual subordinated bonds publicly offered to professional investors by its subsidiary Shenwan Hongyuan Securities, with an issue size of RMB 2 billion and a coupon rate of 1.89%, featuring a floating rate reset every five years; Shenwan Hongyuan Securities has been approved to publicly issue perpetual subordinated bonds of up to RMB 30 billion in aggregate face value, and the bonds are proposed to be listed on the Shenzhen Stock Exchange after registration.
Tag： SWHYHK06806.HKBond Issuance
18:19
【CSPC PHARMA (01093.HK): SYH9087, China's First Subcutaneous Rotigotine Long-acting Product, Cleared for Clinical Trials】On 9 September 2026, CSPC Pharmaceutical Group Limited (01093.HK) announced in a voluntary announcement that its rotigotine long-acting injection (SYH9087), a dopamine receptor agonist, had received NMPA approval for clinical trials in China, becoming the first subcutaneous rotigotine long-acting product cleared for clinical studies in China; the product is dosed once weekly without preparation, and the approved indication is Parkinson's disease.
Tag： CSPC PHARMA01093.HKR&D Progress
18:17
【CSPC PHARMA (01093.HK): SYH9102, World's First Ready-to-use Goserelin Extended-release Injection, Cleared for Clinical Trials in China】On 9 September 2026, CSPC Pharmaceutical Group Limited (01093.HK) announced in a voluntary announcement that its goserelin extended-release injection (SYH9102), a GnRH receptor agonist, had received NMPA approval for clinical trials in China, becoming the world's first ready-to-use goserelin extended-release injection cleared for clinical studies; the product is dosed once monthly without preparation, showed superior castration rates and maintenance versus marketed microsphere formulations in preclinical studies, and the approved indication is solid tumours.
Tag： CSPC PHARMA01093.HKClinical Trial
17:55
【SUNSHINE OIL (02012.HK): AI Computing Power Joint Venture Incorporated under the Name Dineng Zhisuan AI (Qinhuangdao Beidaihe District) Co., Ltd.】On 9 September 2026, Sunshine Oilsands Ltd. (02012.HK) issued a supplementary announcement stating that its AI computing power joint venture with multiple partners had completed industrial and commercial registration and been formally incorporated as Dineng Zhisuan AI (Qinhuangdao Beidaihe District) Co., Ltd. (originally proposed as Dineng Zhisuan AI (Beidaihe) Co., Ltd.); joint venture partner Jiangsu Zhongke Supply Chain Management Co., Ltd. was renamed Zhongke (Nanjing) Investment Holdings Co., Ltd., and the project's design plan has been finalised with approval procedures underway.
Tag： SUNSHINE OIL02012.HKjoint venture
17:30
【EPS HEALTH TECH (03860.HK): Controlling Shareholder to Sell Up to 130 Million Shares at HKD 0.63 Each】On 9 September 2026, EPS HEALTH TECH (03860.HK) announced that controlling shareholder EPS HD agreed to sell up to 130 million shares (22.32%) to Wisdoms Group in two tranches at HKD 0.63 per share.
Tag： EPS HEALTH TECH03860.HKshare disposal
17:24
【HK shares ETFs Daily Report :Korea and Semiconductor Themes Lead While Biotech and Consumer Sectors Under Pressure】On September 9, 2026, the HK shares ETFs market traded in a divergent pattern. Korea and semiconductor themes led the market, with CSOP KOSPI 200 ETF (03121.HK) rising 2.28% to top the daily gainers list, while Asian semiconductor, AI infrastructure and Taiwan themes broadly strengthened. On the downside, consumer and biotech sectors pulled back, with Global X China Consumer Brand ETF (02806.HK) down 1.70% to lead the losers; biotech, India and baijiu themes also weakened. Among southbound Stock Connect ETFs, defensive high-dividend products edged up while Hang Seng TECH and biotech themes came under pressure, broadly in line with the direction of the broader market.
Tag： HK Shares ETFs Daily ReportCSOP KOSPI 200 ETFE Fund (Hk) Solactive Asia Semiconductor Select Index EtfGlobal X China Consumer Brand Etf
17:22
【HAIDILAO (06862.HK): Controlling Shareholder SP NP Disposes 259 Million Shares via Block Trade】On 9 September 2026, HAIDILAO (06862.HK) announced that controlling shareholder group member SP NP sold 259 million shares at HKD 10.62 each via a block trade on 8 September; following the disposal, the controlling shareholders hold approximately 45.49% and control remains unchanged.
Tag： HAIDILAO06862.HKshare disposal
17:08
【VIEWTRIX TECH (03310.HK): Appoints Mr. Yao Xun as Board Secretary】On 9 September 2026, VIEWTRIX TECH (03310.HK) announced the appointment of Yao Xun as board secretary, effective 9 September 2026; Mr. Yao previously served as a director and sponsor representative in CICC's investment banking department.
Tag： VIEWTRIX TECH03310.HK
17:05
【MINIEYE (02431.HK): Chairman Dr. Liu Guoqing Increases H Share Holdings】On 9 September 2026, MINIEYE (02431.HK) announced that Chairman and General Manager Liu Guoqing purchased 100,000 H shares on the open market at an average price of approximately HKD 2.4020 each, raising his beneficial stake to approximately 7.8% and, with concert parties, to approximately 17.60%.
Tag： MINIEYE02431.HKIncrease in Holdings
16:57
【TG SMART ENERGY (01083.HK): Re-designation of Mr. Liao Jili as Independent Non-Executive Director】On 9 September 2026, TG SMART ENERGY (01083.HK) announced the re-designation of Liao Jili as an independent non-executive director and board committee member.
Tag： TG SMART ENERGY01083.HKBoard Change
16:54
【BAMBOOSHEALTH (02293.HK): Expects Annual Profit to Fall to HKD 6-7 Million】On 9 September 2026, BAMBOOSHEALTH (02293.HK) issued a profit warning, expecting annual net profit attributable to shareholders of HKD 6-7 million, down from approximately HKD 17.5 million a year earlier, weighed by keener competition from the imported labour scheme, FX losses and higher clinic costs.
Tag： BAMBOOSHEALTH02293.HK
16:09
【Shanghai-Shenzhen Stock Connect ETFs Daily Report: Coal and Power Grid Equipment Lead Gains; Media and Healthcare Pull Back Collectively - 20260909】On September 9, 2026, the Shanghai-Shenzhen Stock Connect ETFs market continued its pattern of structural divergence. Cyclical resource themes including coal, power grid equipment and non-ferrous metals kept strengthening and led the gainers; meanwhile, media, innovative drugs and real estate sectors faced notable selling pressure and led the decliners.
Tag： Shanghai-Shenzhen Stock Connect ETFs Daily ReportGuotai CSI Coal ETFGuotai Hang Seng China A Electricity Equipment ETFRongtong CSI Chengtong Central Enterprise Dividends ETF
14:54
【ChinaAMC NASDAQ 100 ETF (03086.HK) Rises 0.20% Intraday, Average Price at HK$60.389】As of 13:51, September 9, 2026, ChinaAMC NASDAQ 100 ETF (03086.HK) climbed 0.20% to HK$60.400.
Tag： ChinaAMC NASDAQ 100 ETF03086.HK
14:50
【Ishares Nasdaq 100 Index Etf (02834.HK) Rises 0.21% Intraday, AUM at HK$1.776 Billion】As of 14:12, September 9, 2026, Ishares Nasdaq 100 Index Etf (02834.HK) climbed 0.21% to HK$568.000.
Tag： Ishares Nasdaq 100 Index Etf02834.HKETF
14:45
【Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) Rises 0.44% Intraday, Turnover at HK$8.1946 Million】As of 14:44, September 9, 2026, Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) climbed 0.44% to HK$11.470.
Tag： Samsung S&P Gsci Crude Oil Er Futures Etf03175.HKETF
14:40
【CSOP Gold Futures Daily (2x) Leveraged Product (07299.HK) Rises 0.50% Intraday at HK$24.180】As of 14:38, September 9, 2026, CSOP Gold Futures Daily (2x) Leveraged Product (07299.HK) climbed 0.50% to HK$24.180.
Tag： CSOP Gold Futures Daily (2x) Leveraged Product07299.HKETF
Previous1..910 111213..523     523 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments